MedTrace Logo

Anesthetics and Analgesics in Children

NCT03427736 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-04-29

No results posted yet for this study

Summary

The purpose of this study is to characterize the pharmacokinetic (PK) and safety profile of anesthetics and analgesics in children and adolescents.

Conditions

Interventions

DRUG

Hydromorphone

IV Hydromorphone will be given per standard of care, not prescribed for this study

DRUG

Ketamine

IV Ketamine will be given per standard of care, not prescribed for this study

DRUG

Oxycodone

PO Oxycodone(solution or tablet) will be given per standard of care, not prescribed for this study

DRUG

Morphine

IV Morphine will be given per standard of care, not prescribed for this study

DRUG

Ketorolac Tromethamine

IV ketorolac will be given per standard of care, not prescribed for this study

Sponsors & Collaborators

  • The Emmes Company, LLC

    collaborator INDUSTRY

  • Chi Dang Hornik

    lead OTHER

Principal Investigators

  • Chi Hornik, PharmD · Duke Clinical Research Institute

Eligibility

Min Age
0 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-13
Primary Completion
2027-08-30
Completion
2027-09-09
FDA Drug
Yes

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03427736 on ClinicalTrials.gov